[Retracted] Effects of Gemcitabine and Oxaliplatin Combined with Apatinib on Immune Function and Levels of SIL-2R and sicAM-1 in Patients with Gallbladder Cancer

Table 4

Comparison of survival indicators.

Group	Observation group	Control group	Statistical index	index
	(n = 58)	(n = 58)
Survival rate	39(67.24)	46(79.31)	0.201	0.014
Time (months)	8.15 1.23	10.93 1.26	4.303	0.021
PFs (months)	4.96 1.15	5.43 1.08	5.133	0.004
0s (months)	7.85 1.04	9.53 1.23	2.854	0.038